KDT 501

• CAT Number: I007492
• CAS Number: 1374259-84-3 (potassium salt)
• Molecular Formula: C21H33KO5
• Molecular Weight: 404.59
• Purity: ≥95%
• Synonyms: KDT-501; KDT 501; KDT 501;potassium (1S,5R)-2-hydroxy-5-isopentyl-3-(3-methylbutanoyl)-1-(4-methylpentanoyl)-4-oxocyclopent-2-en-1-olate
• Target: PPAR agonist
• Solubility: Soluble in DMSO
• Storage: 0 - 4°C for short term , or -20°C for long term.
• InChI: InChI=1S/C21H34O5.K/c1-12(2)7-9-15-19(24)18(16(22)11-14(5)6)20(25)21(15,26)17(23)10-8-13(3)4;/h12-15,25-26H,7-11H2,1-6H3;/t15-,21+;/m0./s1
• InChIKey: UITNYUBENTZLRK-QWABXWKJSA-N
• SMILES: CC(C)CC[C@H]1C(=O)C(=C([C@@]1(C(=O)CCC(C)C)O)O)C(=O)CC(C)C.[K]

KDT-501（Cat No.:I007492）is an investigational small molecule compound being developed for its potential in treating autoimmune diseases, particularly conditions like rheumatoid arthritis. It works by targeting specific immune system pathways to modulate inflammation and immune cell activation, with the goal of reducing the symptoms and progression of autoimmune disorders. KDT-501 has shown promise in preclinical studies by inhibiting pro-inflammatory signaling pathways, thereby helping to control excessive immune responses. Ongoing clinical trials are evaluating its safety, efficacy, and therapeutic potential for managing autoimmune diseases and other inflammatory conditions.